Fast Neutrons Help Produce Medical Isotopes
|
By MedImaging International staff writers Posted on 21 Jun 2015 |
|
Image: Chemist Amanda Youker purifying molybdenum-99 (Photo courtesy of Wes Agresta/ ANL).
An innovative process is being used to create a stable commercial source of molybdenum radioisotopes, widely used in diagnostic imaging.
Developed by researchers at Argonne National Laboratory (ANL; Lemont, IL, USA), in cooperation with SHINE Medical Technologies (Monona, WI, USA) the process uses fast neutrons to bombard an aqueous solution of low enriched uranium (LEU), creating fission products that include molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), a radioactive tracer element used in more than 40 million medical diagnostic procedures each year in the United States alone.
The isotope is created when Mo-99 spontaneously decays through the release of a beta particle from its nucleus. Because of its unstable nature, Mo-99 does not occur naturally and is traditionally produced using highly enriched uranium (HEU) in nuclear reactors. Mo-99 is also not produced in the United States, leaving the country to rely on isotope supply from international sources, including a Canadian research reactor that will cease regular production next year, which will reduce the global supply.
The SHINE process is easier to implement, since it involves the bombardment of a LEU uranyl sulfate solution with fast neutrons generated on-site in the ANL linear accelerator. The LEU breaks down after bombardment into hundreds of different isotopes, including Mo-99, which is the result of six percent of the fissions created during the process. The Mo-99 must then be separated from the other fission products before it can be transported for use.
“The development of techniques for domestic production of Mo-99 is a critical national priority and one fully supported by our work at Argonne,” said George Vandegrift, PhD, an ANL distinguished fellow who leads the Mo-99 development efforts. “Millions of patients each year rely on Mo-99 for life-saving diagnostic procedures, but the stability and safety of that supply is threatened by a variety of factors.”
Tc-99m is used in about 85% of all medical imaging procedures worldwide. It is currently made in reactors in Canada, the Netherlands, Belgium, France, Australia, and South Africa.
Related Links:
Argonne National Laboratory
SHINE Medical Technologies
Developed by researchers at Argonne National Laboratory (ANL; Lemont, IL, USA), in cooperation with SHINE Medical Technologies (Monona, WI, USA) the process uses fast neutrons to bombard an aqueous solution of low enriched uranium (LEU), creating fission products that include molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), a radioactive tracer element used in more than 40 million medical diagnostic procedures each year in the United States alone.
The isotope is created when Mo-99 spontaneously decays through the release of a beta particle from its nucleus. Because of its unstable nature, Mo-99 does not occur naturally and is traditionally produced using highly enriched uranium (HEU) in nuclear reactors. Mo-99 is also not produced in the United States, leaving the country to rely on isotope supply from international sources, including a Canadian research reactor that will cease regular production next year, which will reduce the global supply.
The SHINE process is easier to implement, since it involves the bombardment of a LEU uranyl sulfate solution with fast neutrons generated on-site in the ANL linear accelerator. The LEU breaks down after bombardment into hundreds of different isotopes, including Mo-99, which is the result of six percent of the fissions created during the process. The Mo-99 must then be separated from the other fission products before it can be transported for use.
“The development of techniques for domestic production of Mo-99 is a critical national priority and one fully supported by our work at Argonne,” said George Vandegrift, PhD, an ANL distinguished fellow who leads the Mo-99 development efforts. “Millions of patients each year rely on Mo-99 for life-saving diagnostic procedures, but the stability and safety of that supply is threatened by a variety of factors.”
Tc-99m is used in about 85% of all medical imaging procedures worldwide. It is currently made in reactors in Canada, the Netherlands, Belgium, France, Australia, and South Africa.
Related Links:
Argonne National Laboratory
SHINE Medical Technologies
Adjustable Mobile Barrier
M-458
High-Precision QA Tool
DEXA Phantom
Diagnostic Ultrasound System
DC-80A
MRI System
nanoScan MRI 3T/7T
Latest Nuclear Medicine News
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
Channels
Radiography
view channel
X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
Detecting early-stage cancer or subtle changes deep inside tissues has long challenged conventional X-ray systems, which rely only on how structures absorb radiation. This limitation keeps many microstructural... Read more
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
MRI
view channel
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
Ultrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read more
General/Advanced Imaging
view channel
3D Scanning Approach Enables Ultra-Precise Brain Surgery
Precise navigation is critical in neurosurgery, yet even small alignment errors can affect outcomes when operating deep within the brain. A new 3D surface-scanning approach now provides a radiation-free... Read more
AI Tool Improves Medical Imaging Process by 90%
Accurately labeling different regions within medical scans, a process known as medical image segmentation, is critical for diagnosis, surgery planning, and research. Traditionally, this has been a manual... Read more
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more